Christine Pellizzari
2020 - INSMED
In 2020, Christine Pellizzari earned a total compensation of $3.2M as Chief Legal Officer at INSMED, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,300 |
|---|---|
| Option Awards | $1,875,065 |
| Salary | $476,150 |
| Stock Awards | $624,981 |
| Other | $11,400 |
| Total | $3,232,896 |
Pellizzari received $1.9M in option awards, accounting for 58% of the total pay in 2020.
Pellizzari also received $245.3K in non-equity incentive plan, $476.2K in salary, $625K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Christine Pellizzari's compensation ranked 3,603rd out of 13,090 executives tracked by ExecPay. In other words, Pellizzari earned more than 72.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,603 out of 13,090 | 73rd |
Division Manufacturing | 1,408 out of 5,617 | 75th |
Major group Chemicals And Allied Products | 527 out of 2,248 | 77th |
Industry group Drugs | 457 out of 1,948 | 77th |
Industry Pharmaceutical Preparations | 343 out of 1,453 | 76th |
Source: SEC filing on April 1, 2021.
Pellizzari's colleagues
We found five more compensation records of executives who worked with Christine Pellizzari at INSMED in 2020.
News
Science 37 Holdings CEO David Coman's 2022 pay slips 4% to $8.1M
March 20, 2023
Science 37 Holdings CEO David Coman's 2021 pay jumps 656% to $8.4M
March 23, 2022
INSMED CEO William Lewis' 2020 pay slips 14% to $6.2M
April 1, 2021
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019